|
|||||
|
|
Preclinical safety and efficacy of andexanet alfa in animal models |
|
| Authors: | G Lu S J Hollenbach D C Baker S Tan A Hutchaleelaha J T Curnutte P B Conley |
| Institution: | Portola Pharmaceuticals Inc., South San Francisco, CA, USA |
| Abstract: | |
| Keywords: | andexanet antidote biomarker bleeding factor Xa inhibitor recombinant protein |